{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:02Z","timestamp":1787004842978,"version":"build-2736575974"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T00:00:00Z","timestamp":1083196800000},"content-version":"vor","delay-in-days":1825,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Surgery"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>\n                    <jats:bold>Objective\u2014<\/jats:bold>\n                    To describe the clinical history of 3 cats with possible hemolytic uremic syndrome (HUS) after renal transplantation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Study Design\u2014<\/jats:bold>\n                    This case series documents historical findings, physical examination findings, clinical pathologic features, necropsy and histopathologic findings of 3 cats with possible HUS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2014<\/jats:bold>\n                    Two cats had chronic renal failure; 1 cat had acute renal failure secondary to ethylene glycol toxicity. A renal transplant was performed in each of the 3 cats without obvious problems. Complications that would support a diagnosis of HUS, including anemia, thrombocytopenia, and azotemia occurred within 24 hours in 1 cat, within 8 days in a second cat, and 2 months after transplantation in the third cat. In 2 cats, HUS was likely secondary to cyclosporine immunosuppression. In the third cat, HUS may have been secondary to allograft rejection. Renal biopsies from all 3 cats were suggestive of HUS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion and Clinical Relevance\u2014<\/jats:bold>\n                    In human beings, HUS in transplant recipients may occur secondary to immunosuppressive drugs, vascular rejection, or recurrence of original disease. Graft loss occurred in all 3 cats in this study and the mortality rate was 100%. Clinicians caring for these patients need to be aware of this disorder because early recognition and treatment is critical in the management of post\u2010transplant HUS.\n                  <\/jats:p>","DOI":"10.1053\/jvet.1999.0135","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T11:30:43Z","timestamp":1287142243000},"page":"135-140","source":"Crossref","is-referenced-by-count":24,"title":["Possible Hemolytic Uremic Syndrome in Three Cats After Renal Transplantation and Cyclosporine Therapy"],"prefix":"10.1111","volume":"28","author":[{"given":"Lillian R.","family":"Aronson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,29]]},"reference":[{"key":"e_1_2_4_2_2","first-page":"2608","article-title":"Cyclosporine\u2010induced hemolytic uremic syndrome: Factors that obscure its diagnosis","volume":"26","author":"Katznelson S","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_4_3_2","first-page":"440","article-title":"Cyclosporine\u2010induced hemolytic uremic syndrome in a heart transplant recipient","volume":"12","author":"Galli FC","year":"1993","journal-title":"J Heart LungTransplant"},{"key":"e_1_2_4_4_2","first-page":"715","article-title":"Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation","volume":"16","author":"Gharpure VS","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90468-0"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V641160"},{"key":"e_1_2_4_7_2","first-page":"3098","article-title":"De novo hemolytic uremia syndrome: A rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine","volume":"24","author":"Lucca LJ","year":"1992","journal-title":"Transplant Proc"},{"key":"e_1_2_4_8_2","first-page":"842","article-title":"Renal transplantation under cyclosporine and FK506 for hemolytic uremic syndrome","volume":"27","author":"Scantleberry VP","year":"1995","journal-title":"Transplant Proc"},{"key":"e_1_2_4_9_2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/oxfordjournals.ndt.a027673","article-title":"Renal transplantation in adults with thrombotic thrombocytopenic purpura\/haemolytic\u2010uraemic syndrome","volume":"11","author":"Conlon PJ","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_4_10_2","first-page":"3068","article-title":"Renal transplantation under FK506 in patients with previous loss of renal function due to hemolytic uremic syndrome","volume":"23","author":"McCauley J","year":"1991","journal-title":"Transplant Proc"},{"key":"e_1_2_4_11_2","first-page":"321","article-title":"Acute hemolysis during cyclosporine therapy successfully treated with vitamin E","volume":"16","author":"Azuma E","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_4_12_2","first-page":"1290","article-title":"Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms","volume":"128","author":"George JN","year":"1993","journal-title":"Hemostas Throm"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996101"},{"key":"e_1_2_4_14_2","first-page":"2094","article-title":"Nature of renal injury associated with cyclosporine","volume":"28","author":"Curtis JJ","year":"1996","journal-title":"Transplant Proc"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188737"},{"key":"e_1_2_4_16_2","first-page":"2398","article-title":"Effect of cyclosporine on prostacyclin synthesis by vascular tissue in rabbits","volume":"15","author":"Neild GH","year":"1983","journal-title":"Transplant Proc"},{"key":"e_1_2_4_17_2","first-page":"1726","article-title":"Cyclosporine\u2010associated hemolytic uremic syndrome in four renal allograft recipients: Resolution without specific therapy","volume":"22","author":"Buturovic J","year":"1990","journal-title":"Transplant Proc"},{"key":"e_1_2_4_18_2","first-page":"2787","article-title":"Occurrence of hemolytic uremic syndrome under cyclosporine treatment: Accident or possible side effect mediated by a lack of prostacyclin\u2010stimulating plasma factor","volume":"15","author":"Leithner C","year":"1983","journal-title":"Transplant Proc"},{"key":"e_1_2_4_19_2","first-page":"1041","article-title":"Prognostic factors of hemolytic uremic syndrome in renal allografts","volume":"25","author":"Candinas D","year":"1993","journal-title":"Transplant Proc"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(83)90090-7"},{"key":"e_1_2_4_21_2","first-page":"1432","article-title":"Unusually larger plasma factor VIII: von Willebrand factor multimers in chronic relapsing trombotic thrombocytopenic purpura","volume":"23","author":"Moake JL","year":"1982","journal-title":"Thrombosis Res"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365599709030646"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90515-6"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198702000-00023"},{"key":"e_1_2_4_25_2","first-page":"110","article-title":"Prostacyclin in thrombotic microangiopathy","volume":"24","author":"Remuzzi G","year":"1987","journal-title":"Semin Hematol"},{"key":"e_1_2_4_26_2","first-page":"228","article-title":"Reversible cyclosporine\u2010associated hemolytic uremic syndrome in a renal transplant recipient: A role for PAF","volume":"18","author":"Dyck RF","year":"1986","journal-title":"Transplant Proc"},{"key":"e_1_2_4_27_2","first-page":"1530","article-title":"Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation","volume":"63","author":"Gelder T","year":"1997","journal-title":"Transplant"},{"key":"e_1_2_4_28_2","first-page":"1256","article-title":"Reversal of cyclosporine\u2010associated hemolytic\u2010uremic syndrome by plasma exchange with fresh\u2010frozen plasma replacement in renal transplant recipients","volume":"23","author":"Venkat KK","year":"1991","journal-title":"Transplant proc"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000185080"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199603000-00007"}],"container-title":["Veterinary Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1053%2Fjvet.1999.0135","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1053\/jvet.1999.0135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T17:35:20Z","timestamp":1698514520000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1053\/jvet.1999.0135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1053\/jvet.1999.0135"],"URL":"https:\/\/doi.org\/10.1053\/jvet.1999.0135","archive":["Portico"],"relation":{},"ISSN":["0161-3499","1532-950X"],"issn-type":[{"value":"0161-3499","type":"print"},{"value":"1532-950X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}